PI3K/AKT pathway acts as a positive regulator of the mTOR pathway, which serves as a negative regulator of autophagy in cancer cells [11], and disruption of the PI3K/AKT/mTOR pathway by anticancer agents induces autophagy. The gene discussed is AKT1; the disease is cancer.